General Motors and LG Chem sign a cathode material supply agreement worth nearly $19 billion
sunny77
发表于 2024-2-8 10:53:48
3838
0
0
On Wednesday local time, LG Chemical in South Korea announced that the company has signed an agreement worth 25 trillion Korean won (approximately 18.8 billion US dollars) to supply cathode materials for electric vehicle batteries to General Motors from this year to 2035. According to the long-term supply contract, LG Chem will supply over 500000 tons of cathode materials (including nickel, cobalt, manganese, and aluminum) to General Motors in 2026-35. LG Chem believes that the estimated total amount of cathode materials will be sufficient to produce approximately 5 million high-performance electric vehicle batteries.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Xiaopeng Motors signs a joint development agreement and enters into a joint procurement plan with Volkswagen Group
- Boeing and US State Department reach a $51 million settlement agreement on illegal exports
- South Grid Energy Storage Technology and NIO Energy Sign an Agreement
- Photovoltaic energy storage leader announces signing of 3.5GW supply agreement!
- Apple and Consumers Revise $35 Million iPhone Audio Settlement Agreement
- AstraZeneca and Sinopharm Group reach nearly $2 billion cardiovascular drug authorization agreement
- Zhihu and Tencent renew framework agreement
- Beike terminates its agreement to acquire equity in Space Intelligence
- Kaken signs Stat6 global licensing agreement with Johnson&Johnson
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered